Avidity Partners Management’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History

Avidity Partners Management’s Portfolio GRTS Stock Details GRTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-2,733,800	Closed	-$4.7M	–	92
2023 Q3	$4.7M	Sell	2,733,800 -31,700	-1%	-$56.3K	0.19%	73
2023 Q2	$5.39M	Buy	+2,765,500	New	+$6.48M	0.19%	80
2022 Q2	–	Sell	-560,000	Closed	-$2.31M	–	99
2022 Q1	$2.31M	Sell	560,000 -3,810,000	-87%	-$20.2M	0.05%	84
2021 Q4	$56.2M	Sell	4,370,000 -87,831	-2%	-$973K	1.19%	33
2021 Q3	$48.1M	Buy	4,457,831 +2,335,767	+110%	+$21.3M	1.07%	31
2021 Q2	$19.4M	Hold	2,122,064	–	–	0.52%	53
2021 Q1	$20M	Hold	2,122,064	–	–	0.55%	59
2020 Q4	$8.36M	Buy	+2,122,064	New	+$6.42M	0.27%	70

Other funds holding GRTS

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

VVM

Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Avidity Partners Management's GRTS Position: Q4 2023 in Review

Avidity Partners Management sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q4 2023, closing a stake of 2,733,800 shares — an estimated $4.7M sold.

Avidity Partners Management first reported a position in GRTS in Q4 2020 and held it in 8 quarters. The position peaked at $56.2M in Q4 2021. 88 funds tracked by Wall St. Rank hold GRTS as of Q4 2023.

Avidity Partners Management reported no remaining Gritstone bio, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Avidity Partners Management sold 2,733,800 Gritstone bio, Inc. Common Stock shares in Q4 2023, an estimated $4.7M.
Avidity Partners Management first reported a position in Gritstone bio, Inc. Common Stock in Q4 2020 and held it in 8 quarters.
Avidity Partners Management's Gritstone bio, Inc. Common Stock position peaked at $56.2M in Q4 2021.
88 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q4 2023.

Based on Avidity Partners Management's 13F filing for Q4 2023, filed 14 Feb 2024.